BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26518132)

  • 1. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.
    Liu H; Yang HL; Xu JW; Wang JZ; Nie RH; Li CF
    Malar J; 2013 Nov; 12():409. PubMed ID: 24215565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
    Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
    PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.
    Wangchuk S; Drukpa T; Penjor K; Peldon T; Dorjey Y; Dorji K; Chhetri V; Trimarsanto H; To S; Murphy A; von Seidlein L; Price RN; Thriemer K; Auburn S
    Malar J; 2016 May; 15(1):277. PubMed ID: 27176722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
    Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
    Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
    Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
    Siqueira AM; Alencar AC; Melo GC; Magalhaes BL; Machado K; Alencar Filho AC; Kuehn A; Marques MM; Manso MC; Felger I; Vieira JL; Lameyre V; Daniel-Ribeiro CT; Lacerda MV
    Clin Infect Dis; 2017 Jan; 64(2):166-174. PubMed ID: 27988484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors.
    Gomes Mdo S; Vieira JL; Machado RL; Nacher M; Stefani A; Musset L; Legrand E; Menezes RA; Júnior AA; Sousa AP; Couto VS; Couto ÁA
    Malar J; 2015 Oct; 14():402. PubMed ID: 26453152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.
    Warrasak S; Euswas A; Fukuda MM; Ittiverakul M; Miller RS; Krudsood S; Ohrt C
    Int Ophthalmol; 2019 Aug; 39(8):1767-1782. PubMed ID: 30269312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmodium vivax malaria: treatment of primary attacks with primaquine, in three different doses, and a fixed dose of chloroquine, Antioquia, Colombia, 2003-2004].
    Carmona-Fonseca J; Alvarez G
    Biomedica; 2006 Sep; 26(3):353-65. PubMed ID: 17175999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern Ethiopia.
    Assefa M; Eshetu T; Biruksew A
    Malar J; 2015 Nov; 14():458. PubMed ID: 26577669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response.
    Mekonnen DA; Abadura GS; Behaksra SW; Taffese HS; Bayissa GA; Bulto MG; Tessema TS; Tadesse FG; Gadisa E
    Malar J; 2023 Apr; 22(1):135. PubMed ID: 37098510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.